Cell Therapy Manufacturing Market, by Therapy Type (Allogeneic Cell Therapy, Autologous Cell Therapy), by Technology Type (Somatic Cell Technology, Cell Immortalization, Technology, Viral Vector Technology, Genome Editing, Technology, Cell Plasticity Tech

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	205 Pages	Coherent Market Insights	November, 2022	CMI17549933

Best Price Guarantee
Price	from $4,500
Length	205 Pages
Publisher	Coherent Market Insights
Published Date	November, 2022
SKU	CMI17549933

Cell Therapy Manufacturing Market, by Therapy Type (Allogeneic Cell Therapy, Autologous Cell Therapy), by Technology Type (Somatic Cell Technology, Cell Immortalization, Technology, Viral Vector Technology, Genome Editing, Technology, Cell Plasticity Technology, 3D Technology), by Source (IPSC’s (Induced pluripotent stem cell), Bone Marrow, Umbilical Cord, Adipose Tissue, Neural Stem), by Application (Musculoskeletal, Cardiovascular, Gastrointestinal, Neurological, Oncology, Dermatology, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Cellular treatment uses living cells to kill and regulate cancer cells. Cellular therapy, according to researcher, uses the cell itself as medicine, in place of pharmaceuticals. As an illustrative example, adoptive T-cell transfer, also known as adoptive cell therapy, is a procedure that involves removing cancer-killing T cells from the patient's blood, boosting their number in a lab, and then reintroducing them to the patient to bolster the immune system's fight against the illness.

The cell therapy market is expected to gain further traction, with evolving treatment options and rapid technological innovation in cell therapy. Fewer side effects, high effectiveness and potent action, and ability to cure the disease are some of the major advantages of cell therapy. Roswell Park, a cancer treatment center, treats specific types of leukemia and lymphoma with Kymriah (tisagenlecleucel), Tecartus (brexucabtagene autoleucel) and Yescarta (axicabtagene ciloleucel), and to treat multiple myeloma with Abecma (idecabtagene vicleucel). Cellular therapies may also be available through clinical trials for the treatment of Metastatic melanoma, Multiple myeloma, Neuroblastoma and synovial cell carcinoma, ovarian cancer, etc.

Market Dynamics

The increasing government initiatives for the advancement in the manufacturing of cell therapy is expected to fuel the market growth over the forecast period. For instance, on February 15, 2022, Brainstorm Cell Therapeutics Inc., a developer of adult stem cell therapeutics for neurodegenerative diseases, announced that the Brazilian Patent Office approved a patent Technology Type titled A method of generating cells which secrete Brain Derived Neurotrophic Factor (BDNF), Glial Derived Neurotrophic Factor (GDNF), Hepatocyte Growth Factor (HGF) and Vascular Endothelial Growth Factor (VEGF), wherein said cells do not Secrete Nerve Growth Factor (NGF).

Key features of the study:

This report provides an in-depth analysis of the global cell therapy manufacturing market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cell therapy manufacturing market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include WuXi AppTec, Inc., Lineage Cell Therapeutics, Inc., HEALIOS K.K., Lonza, Merck KGaA., Takara Bio Inc., Sumitomo Dainippon Pharma Co., LTD, Fujifilm Holdings Corporation, Thermo Fisher Scientific, Inc., Astellas Pharma Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global cell therapy manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell therapy manufacturing market

Detailed Segmentation:

Global Cell Therapy Manufacturing Market, By Therapy Type:
Allogeneic Cell Therapy
Autologous Cell Therapy
Global Cell Therapy Manufacturing Market, By Technology Type:
Somatic Cell Technology
Cell ImmortalizationTechnology
Viral Vector Technology
Genome Editing Technology
Cell Plasticity Technology
3D Technology
Global Cell Therapy Manufacturing Market, By Source:
IPSC’s (Induced pluripotent stem cell)
Bone Marrow
Umbilical Cord
Adipose Tissue
Neural Stem
Global Cell Therapy Manufacturing Market, By Application:
Musculoskeletal
Cardiovascular
Gastrointestinal
Neurological
Oncology
Dermatology
Others
Global Cell Therapy Manufacturing Market, By Region:
North America

By Country

U.S.
Canada
Latin America

By Country

Brazil
Mexico
Argentina
Rest of Latin America
Europe

By Country

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific

By Country

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East

By Country

GCC
Israel
Rest of Middle East
Africa

By Region/Country

South Africa
Central Africa
North Africa
Company Profiles
WuXi AppTec, Inc.

Company Highlights

Products Portfolio

Key Highlights

Financial Performance

Strategies

Lineage Cell Therapeutics, Inc.,
HEALIOS K.K.,
Lonza,
Merck KGaA.,
Takara Bio Inc.,
Sumitomo Dainippon Pharma Co., LTD.
Fujifilm Holdings Corporation
Thermo Fisher Scientific, Inc.
Astellas Pharma Inc.

“*” marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Therapy Type; Market Snapshot, By Technology Type; Market Snapshot, By Source; Market Snapshot, By Application; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Market Opportunities; Impact Analysis; Market Trends; Recent Developments; Acquisitions and Partnerships Scenario; Technology Overview; Regulatory Scenario; Pipeline Analysis; PEST Analysis
4. Global Cell Therapy Manufacturing Market- Impact of Coronavirus (Covid-19) Pandemic: Overall Impact; Impact on Supply and Demand; COVID-19 Impact on the market
5. Global Cell Therapy Manufacturing Market, By Therapy Type, 2017 – 2030, (US$ Million): Overview; Market Share Analysis, 2022 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Allogeneic Cell Therapy; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million); Autologous Cell Therapy; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
6. Global Cell Therapy Manufacturing Market, By Technology Type, 2017 – 2030, (US$ Million): Overview; Market Share Analysis, 2022 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Somatic Cell Technology; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million); Cell Immortalization Technology; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million); Viral Vector Technology; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million); Genome Editing Technology; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million); Cell Plasticity Technology; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
3D Technology: Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
7. Global Cell Therapy Manufacturing Market, By Source, 2017 – 2030, (US$ Million): Overview; Market Share Analysis, 2022 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; IPSC’s (Induced pluripotent stem cell); Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million); Bone Marrow; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million); Umbilical Cord; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million); Adipose Tissue; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million); Neural Stem; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
8. Global Cell Therapy Manufacturing Market, By Application, 2017 – 2030, (US$ Million): Overview; Market Share Analysis, 2022 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Musculoskeletal; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million); Cardiovascular; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million); Gastrointestinal; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million); Neurological; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million); Oncology; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million); Dermatology; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million); Others; Overview; Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
9. Global Cell Therapy Manufacturing Market, By Region, 2017 – 2030, (US$ Million): Introduction; Market Share Analysis, By Region, 2022 and 2030 (%); Y-o-Y Growth Analysis, For Regions, 2017–2030; Regional Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Technology type, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Technology Type, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Source, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million); Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Million); North Africa; Central Africa; South Africa; 10. Competitive Landscape; WuXi AppTec, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Lineage Cell Therapeutics, Inc.,; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; HEALIOS K.K.,; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Lonza; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Merck KGaA; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Takara Bio Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Sumitomo Dainippon Pharma Co., LTD.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Fujifilm Holdings Corporation; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Thermo Fisher Scientific, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Astellas Pharma Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; 11. Section; Research Methodology; About Us; *Browse 41 market data tables and 32 figures on "Global Cell therapy Manufacturing Market” - forecast to 2030